Factores de riesgo cardiovascular lipídicos y no lipídicos en una población adulta / Lipid and non-lipid cardiovascular risk factors in an adult population / Fatores de risco cardiovascular lipídicos e não-lipídicos em uma população adulta

Las enfermedades cardiovasculares (EC) constituyen la principal causa de muerte de la población adulta, por lo que es importante conocer y controlar los factores de riesgo. El propósito del estudio fue evaluar el nivel de riesgo cardiovascular asociado a lípidos séricos y otros factores de riesgo no lipídicos, en una población adulta. Se realizó un estudio descriptivo y transversal en 95 adultos de 23-51 años (44 mujeres, 51 hombres). Se determinaron la glucosa, el perfil lipídico, el ácido úrico y la proteína C reactiva en suero. Se midió la presión arterial, el peso, la talla y se calculó el índice de masa corporal. Se obtuvieron datos sobre antecedentes familiares de EC, diabetes o hipertensión, hábitos de tabaco y alcohol y actividad física. Los resultados mostraron que los adultos del sexo masculino y aquellos con más de 30 años de edad presentaron mayor frecuencia de factores de riesgo lipídicos, así como una mayor prevalencia de alteraciones para los índices de riesgo cardiometabólico, respecto al sexo femenino y a los menores de 30 años. Igualmente, los hombres mostraron mayor prevalencia de algunos factores de riesgo no lipídicos (ácido úrico elevado, sobrepeso, presión arterial elevada). Aunque se encontró una baja prevalencia en cuanto a la acumulación de factores de riesgo lipídicos, una proporción importante de la muestra presentó 3 o más factores de riesgo no lipídicos. Adicionalmente, más del 70% de los adultos evaluados, presentó 3 o más factores de riesgo lipídicos o no lipídicos. Estos hallazgos sugieren la necesidad de implementar modelos de promoción de salud y prevención de la enfermedad que integren el conocimiento, la detección y el manejo de los factores de riesgo con base en la modificación de estilos de vida.

Cardiovascular disease (CVD) is the leading cause of death in the adult population, so it is important to know and control the risk factors. The purpose of the study was to assess the level of cardiovascular risk associated with serum lipids and other non-lipid risk factors in an adult population. A descriptive study was made on 95 adults of 23-51 years of age (44 women, 51 men). Glucose, lipid profile, uric acid and C-reactive protein in serum were determined. Blood pressure, weight and height were measured and body mass index was calculated. Data on family history of CVD, diabetes or hypertension, smoking and alcohol habits and physical activity were obtained. The results showed that male adults and those over 30 years of age had a higher frequency of lipid risk factors, as well as a higher prevalence of alterations to cardio metabolic risk indices, compared to women and adults less than 30 years old. Men also showed greater prevalence of some non-lipid risk factors (high uric acid, obesity and high blood pressure). Although a low prevalence was found in terms of the accumulation of lipid risk factors, a significant proportion of the sample presented 3 or more non-lipid risk factors. Additionally, over 70% of adults evaluated showed 3 or more lipid or non-lipid risk factors These findings suggest the need to implement models of health promotion and disease prevention, integrating knowledge, detection and management of risk factors based on lifestyle changes.

As doenças cardiovasculares (DCV) são a principal causa de morte da população adulta, por isso é importante conhecer e controlar os fatores de risco. O objetivo do estudo foi avaliar o nível de risco cardiovascular associado a lipídios séricos e outros fatores de risco não-lipídicos em uma população adulta. Realizou-se um estudo descritivo e transversal em 95 adultos de 23-51 anos (44 mulheres, 51 homens). Foram determinados glicose, perfil lipídico, ácido úrico e proteína C-reativa em soro. Foi medida a pressão arterial, peso, altura e se calculou o índice de massa corporal. Obtiveram-se dados sobre história familiar de doenças cardiovasculares, diabetes ou hipertensão, hábitos de álcool e tabagismo e atividade física. Os resultados mostraram que os homens adultos e as pessoas com mais de 30 anos de idade apresentaram maior frequência de fatores de risco lipídicos, bem como uma maior prevalência de alterações para os índices de risco cardiometabólico, em comparação com as mulheres e os menores de 30 anos. Os homens também apresentaram maior prevalência de alguns fatores de risco não lipídicos (ácido úrico elevado, obesidade, pressão arterial elevada). Embora tenha sido encontrada baixa prevalência em termos de acumulação de fatores de risco de lipídios, uma proporção significativa da amostra apresentou três ou mais fatores de risco não-lipídicos. Além disso, mais de 70% dos adultos avaliados mostrou 3 ou mais fatores de risco lipídico ou não-lipídico. Estes achados sugerem a necessidade da implementação de modelos de promoção da saúde e prevenção de doenças, integrando o conhecimento, detecção e gestão dos fatores de risco com base na mudança de estilos de vida.

Hiperqueratosis acral focal asociada a queratolisis punteada / Focal acral hyperkeratosis associated with pitted keratolysis

La hiperqueratosis acral focal se caracteriza por el mismo aspecto clínico que la acroqueratoelastoidosis, pero sin anormalidades en las fibras elásticas. Presentamos el caso de una mujer con dermatosis localizada en palmas, plantas y dorso de articulaciones metacarpofalángicas, de 10 años de evolución, constituida por múltiples pápulas poligonales e hiperhidrosis asociadas, clínicamente compatibles con acroqueratoelastoidosis. Tenía el antecedente de enfermedad en el padre. Además, la paciente presentaba queratolisis punteada palmoplantar. Además, la paciente presentaba queratolisis punteada palmoplantar. El estudio histopatológico descartó elastorrexis y la queratolisis punteada se corroboró por el aspecto clínico y la presencia de elementos cocoides en la capa córnea, evidentes con tinción de PAS. En nuestra opinión, la hiperqueratosis acral focal no constituye una entidad independiente de la acroqueratoelastoidosis

Focal acral hyperkeratosis is characterized by the same clinical appearance as acrokeratoelastoidosis, but without abnormalities in the elastic fibers. We present the case of a woman with a 10-year case of dermatosis localized on the palms, soles and dorsum of the metacarpophalangeal joints, consisting of multiple polygonal papules and associated hyperhydrosis, clinically compatible with acrokeratoelastoidosis. Her father had a history of the disease. In addition, the patient presented with palmoplantar pitted keratolysis. The histopathological study ruled out elastorrhexis, and the pitted keratolysis was corroborated by the clinical appearance and the presence of coccoid elements in the stratum corneum, evident with a PAS stain. In our opinion, the focal acral hyperkeratosis is not a separate entity from the acrokeratoelastoidosis

[Focal acral hyperkeratosis associated with pitted keratolysis]. / Hiperqueratosis acral focal asociada a queratolisis punteada.

Focal acral hyperkeratosis is characterized by the same clinical appearance as acrokeratoelastoidosis, but without abnormalities in the elastic fibers. We present the case of a woman with a 10-year case of dermatosis localized on the palms, soles and dorsum of the metacarpophalangeal joints, consisting of multiple polygonal papules and associated hyperhydrosis, clinically compatible with acrokeratoelastoidosis. Her father had a history of the disease. In addition, the patient presented with palmoplantar pitted keratolysis. The histopathological study ruled out elastorrhexis, and the pitted keratolysis was corroborated by the clinical appearance and the presence of coccoid elements in the stratum corneum, evident with a PAS stain. In our opinion, the focal acral hyperkeratosis is not a separate entity from the acrokeratoelastoidosis.

A double-blind study of the efficacy and safety of the ICP10deltaPK vaccine against recurrent genital HSV-2 infections.

A randomized double-blind trial to evaluate the safety of a novel recombinant virus, ICP10deltaPK, for reduction or prevention of recurrent herpes simplex virus type 2 (HSV-2) infection was carried out in public hospitals in Mexico City. Persons having a minimum of 5 documented herpetic recurrences in the previous year were randomized for vaccination. Patients were examined within 72 hours of lesion occurrence. If accepted into the study, the patient was inoculated subcutaneously in the upper deltoid muscle area at days 7, 17, and 28 after initiation of lesion occurrence. Recurrences were recorded by patient diary and physician examination. During the observation period (extending from 10 to 180 days after the last booster dose), recurrences in the vaccine (V) group were prevented completely in 37.5% of the patients, whereas in the placebo (P) group, 100% of the patients had at least one recurrence (P = .068). Vaccinated patients had fewer recurrences (V, 1.58; P, 3.13 [P = .028]). The mean number of illness days was 10 for the vaccine group and 18 for the placebo group (P = .028). Further studies to evaluate this vaccine and its dosimetry for the treatment of genital herpes infections appear warranted.

Neurilemoma: presentación de un caso / Neurilemmoma: report of a case

Se presenta y comenta un caso de neurilemoma en una de sus topografías habituales: cavidad oral. Se trata de una mujer de 23 años de edad, con evolución de 12 años. Asintómatico. El diagnóstico fue histológico y el tratamiento la extirpación quirúrgica.